BCR-ABL kinase-IN-3 (dihydrocholide)

BCR-ABL kinase-IN-3 (dihydrocholide) (example 1) is a potent inhibitor of BCR-ABL that plays an important role in acute myeloid leukemia (AML) research[1].

Product Specifications

UNSPSC

12352005

Target

Bcr-Abl

Type

Reference compound

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/bcr-abl-kinase-in-3-dihydrocholide.html

Solubility

10 mM in DMSO

Smiles

CN(N=C1)C=C1NC2=CC=CN3C2=NC=C3C#CC4=C(C)C=C(F)C(C(NC5=CC(N6C=C(C)N=C6)=CC(C(C#N)(C)C)=C5)=O)=C4.[H]Cl.[H]Cl

Molecular Formula

C35H32Cl2FN9O

Molecular Weight

684.59

References & Citations

[1]Lee Doohyun, et al. Preparation of 3- ((8- ((1H-pyrazol-4-yl) amino) imidazo[1,2-a]pyridin-3-yl) ethynyl) -N-phenylbenzamide derivatives for prevention or treatment of cancer. World Intellectual Property Organization, WO2021172931 A1 2021-09-02